Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Hospital for Special Surgery

Explore full profile

Providing orthopedic, rheumatology and rehabilitation services to the patients

New York City, United StatesFounded 1863Health Tech & Medtech
Valuation $100–250M Last recorded · 2022
Headcount 10–25k Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Hospital for Special Surgery and the history behind them.

About Hospital for Special Surgery

Hospital for Special Surgery (HSS) is a premier medical institution specializing in orthopedics and rheumatology, consistently ranked as the number one hospital in the U.S. for orthopedics and second for rheumatology. HSS serves a diverse clientele, including adults and children, offering a comprehensive range of services from diagnosis to surgery. The hospital operates in the healthcare market, focusing on musculoskeletal health and related conditions. Its business model revolves around providing specialized medical care, leveraging advanced technologies such as computer navigation and robotics in joint replacement surgeries. Revenue is generated through patient services, including consultations, surgeries, and follow-up care. HSS also engages in research and education, contributing to advancements in medical science and training the next generation of healthcare professionals.

Source: Dealroom company data

At a glance

Status
Operational
Founded
1863
Headquarters
New York City, United States
Employees
17,719
Open positions
130
Dealroom signal
46.9/100
Industry
Health, Sports
Sub-industry
Health Platform
Sector
Health Tech & Medtech, Surgery
Client focus
b2c
Investment activity
9 companies, latest Oct 2025
Capital deployed
$44M
Preferred round
SERIES A

Funding history

4 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
DEBT✓Debt Oct 2025 $0 — General Atlantic ↗
GRANT✓Other financing Jun 2023 $10M — Stavros Niarchos Foundation Cultural Center ↗
Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

Hospital for Special Surgery website traffic

Latest recorded traffic for Hospital for Special Surgery is 1.5M monthly website visits, up 76.5% over the last three months. Hospital for Special Surgery's team grew 33.4% over the past year.

Latest monthly visits1.5M 3-month web change+76.5% 1-year team growth+33.4%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Investors

3 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

  • Stavros Niarchos Foundation Cultural Center

Series A1 investor entered at this stage

  • Flare Capital Partners

Series B and later1 investor entered at this stage

Team profiled 108 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
99 countries with
team presence
🇺🇸 United States79.8%
🇮🇳 India4.8%
🇮🇷 Iran1.9%
🇪🇬 Egypt0.9%
🇳🇬 Nigeria0.8%
Top 5 of 99 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Hospital for Special Surgery on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Hospital for Special Surgery’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.